Recent Articles from StockStory

StockStory is a financial technology company dedicated to simplifying profitable stock investing for individual investors. By leveraging advanced AI technology and human expertise, it generates detailed, data-driven research reports and monthly stock picks to identify high-quality stocks with strong growth potential. The company aims to democratize access to sophisticated analytical methods and proprietary datasets—previously exclusive to elite hedge funds—delivering clear, actionable insights rather than complex, do-it-yourself tools. With a mission to level the playing field in a market often favoring large institutions, StockStory provides retail investors with the resources to make informed, market-beating investment decisions.

5 Insightful Analyst Questions From Pediatrix Medical Group’s Q4 Earnings Call
Pediatrix Medical Group’s fourth quarter was marked by a negative market reaction, driven by a combination of lower-than-expected non-GAAP earnings and year-on-year revenue declines. Management attributed the softer results primarily to a decrease in net patient volumes across all service lines, with Chief Financial Officer Kasandra H. Rossi citing "a tough comp" from the prior year as a key factor. Despite these volume pressures, Pediatrix was able to partially offset the impact through favorable payer mix, improved revenue cycle management collections, and higher patient acuity in neonatology, resulting in a notable increase in operating margin compared to the previous year.
Via StockStory · February 26, 2026
5 Insightful Analyst Questions From Lemonade’s Q4 Earnings Call
Lemonade's fourth quarter was marked by significant top-line acceleration and operational progress, though the market responded negatively to the results. Management credited rapid growth in in-force premium, improved marketing efficiency, and the scaling of pet, car, and European businesses as the primary drivers of performance. CEO Daniel Schreiber highlighted that gross profit increased sharply and free cash flow turned positive, noting, “This was our strongest quarter ever,” yet also acknowledged the need to maintain disciplined expense growth. Management’s cautious remarks around the pace of investment and the competitive landscape may have influenced the market’s reaction.
Via StockStory · February 26, 2026
5 Revealing Analyst Questions From Etsy’s Q4 Earnings Call
Etsy’s fourth quarter results were met with a positive market reaction, as the company’s profitability exceeded Wall Street expectations despite ongoing softness in buyer activity. Management attributed this outcome to operational improvements in its core marketplace, such as reorganizing around customer outcomes and investing in targeted marketing, particularly on social channels like TikTok. CEO Kruti Goyal emphasized that enhancements to Etsy’s mobile app and personalized marketing efforts are beginning to drive healthier engagement and retention, noting, “Our app is making it our most personalized and engaging platform.”
Via StockStory · February 26, 2026
The 5 Most Interesting Analyst Questions From Farmer Mac’s Q4 Earnings Call
Farmer Mac’s third quarter was marked by strong business volume growth and an 11% year-over-year increase in sales, despite falling short of Wall Street’s revenue expectations. Management credited the quarter’s positive performance to continued expansion in infrastructure finance, particularly in broadband and renewable energy lending, and highlighted a record net effective spread. CEO Bradford Nordholm emphasized, “Our strategy-driven decision to diversify our loan portfolio into newer lines of business…has been a key priority, and that diversification is benefiting us through changing market cycles.” Operating expenses increased due to higher headcount and technology investments, but these were seen as essential to supporting new business volumes and operational efficiency projects.
Via StockStory · February 26, 2026
Walmart’s Q4 Earnings Call: Our Top 5 Analyst Questions
Walmart’s fourth quarter was marked by robust digital growth and continued market share gains, earning a positive reaction from investors. Management attributed the performance to a strong omnichannel strategy, as e-commerce sales grew 24% globally and new technology investments improved inventory and delivery speeds. CEO John Furner highlighted that customers using Walmart’s AI-powered shopping assistant, Sparky, placed larger orders, saying, “Customer engagement is up, and customers who use Sparky have an average order value that’s about 35% higher than non-Sparky customers.” The company also saw strength in fashion and general merchandise, with both in-store and online sales outperforming expectations. Inventory management improvements, automation, and a focus on higher-margin areas like advertising and membership further supported profit growth.
Via StockStory · February 26, 2026
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow
Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) will be reporting results this Friday morning. Here’s what you need to know.
Via StockStory · February 25, 2026
What To Expect From BrightSpring Health Services’s (BTSG) Q4 Earnings
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) will be announcing earnings results this Friday before market hours. Here’s what to expect.
Via StockStory · February 25, 2026
Globalstar (GSAT) To Report Earnings Tomorrow: Here Is What To Expect
Satellite communications provider Globalstar (NASDAQ:GSAT) will be announcing earnings results this Friday before market open. Here’s what investors should know.
Via StockStory · February 25, 2026
Arbor Realty Trust (ABR) Q4 Earnings: What To Expect
Real estate investment trust Arbor Realty Trust (NYSE:ABR) will be reporting results this Friday before the bell. Here’s what to look for.
Via StockStory · February 25, 2026
DigitalBridge (NYSE:DBRG) Misses Q4 CY2025 Sales Expectations
Digital infrastructure investor DigitalBridge Group (NYSE:DBRG) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 27.6% year on year to $47.9 million. Its GAAP profit of $0.27 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Urban Outfitters (NASDAQ:URBN) Exceeds Q4 CY2025 Expectations
Clothing and accessories retailer Urban Outfitters (NASDAQ:URBN) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.1% year on year to $1.8 billion. Its non-GAAP profit of $1.43 per share was 13.3% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Sterling (NASDAQ:STRL) Reports Bullish Q4 CY2025, Stock Soars
Civil infrastructure construction company Sterling Infrastructure (NASDAQ:STRL) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 51.5% year on year to $755.6 million. The company’s full-year revenue guidance of $3.13 billion at the midpoint came in 10.7% above analysts’ estimates. Its non-GAAP profit of $3.08 per share was 17% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Carriage Services’s (NYSE:CSV) Q4 CY2025 Sales Top Estimates
Funeral services company Carriage Services (NYSE:CSV) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 8% year on year to $105.5 million. The company’s full-year revenue guidance of $445 million at the midpoint came in 3.7% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 7.2% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
DXP (NASDAQ:DXPE) Delivers Impressive Q4 CY2025
Industrial distributor DXP Enterprises (NASDAQ:DXPE) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 12% year on year to $527.4 million. Its non-GAAP profit of $1.39 per share was 6.9% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Nutanix (NASDAQ:NTNX) Exceeds Q4 CY2025 Expectations, Stock Jumps 14%
Hybrid multicloud computing company Nutanix (NASDAQ:NTNX) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 10.4% year on year to $722.8 million. On the other hand, next quarter’s revenue guidance of $685 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $0.56 per share was 28.1% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Montrose (NYSE:MEG) Surprises With Q4 CY2025 Sales
Environmental services provider Montrose (NYSE:MEG) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 2.2% year on year to $193.3 million. The company’s full-year revenue guidance of $870 million at the midpoint came in 2.6% above analysts’ estimates. Its non-GAAP profit of $0.35 per share was 84.4% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
HEICO (NYSE:HEI) Beats Q4 CY2025 Sales Expectations But Stock Drops
Aerospace and defense company HEICO (NSYE:HEI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 14.4% year on year to $1.18 billion. Its GAAP profit of $1.35 per share was 5.1% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Ibotta (NYSE:IBTA) Exceeds Q4 CY2025 Expectations, Stock Jumps 26.4%
Cash-back rewards platform Ibotta (NYSE:IBTA) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 10% year on year to $88.53 million. On top of that, next quarter’s revenue guidance ($80 million at the midpoint) was surprisingly good and 7.9% above what analysts were expecting. Its GAAP loss of $0.04 per share was $0.02 below analysts’ consensus estimates.
Via StockStory · February 25, 2026
GoodRx’s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8%
Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.9% year on year to $194.8 million. On the other hand, the company’s full-year revenue guidance of $765 million at the midpoint came in 6.2% below analysts’ estimates. Its non-GAAP profit of $0.09 per share was in line with analysts’ consensus estimates.
Via StockStory · February 25, 2026
E.W. Scripps (NASDAQ:SSP) Beats Q4 CY2025 Sales Expectations
Media, broadcasting, and digital services company E.W. Scripps (NASDAQ:SSP) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 23.1% year on year to $560.3 million. Its GAAP loss of $0.51 per share was significantly below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Paramount (NASDAQ:PSKY) Posts Q4 CY2025 Sales In Line With Estimates
Multinational media and entertainment corporation Paramount (NASDAQ:PSKY) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 5.1% year on year to $8.15 billion. On the other hand, next quarter’s revenue guidance of $7.25 billion was less impressive, coming in 2.3% below analysts’ estimates. Its GAAP loss of $0.52 per share was significantly below analysts’ consensus estimates.
Via StockStory · February 25, 2026
VSE Corporation’s (NASDAQ:VSEC) Q4 CY2025: Strong Sales
Aviation and fleet aftermarket services provider VSE Corporation (NASDAQ:VSEC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $301.2 million. Its non-GAAP profit of $1.16 per share was 29.9% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
HCI Group (NYSE:HCI) Reports Bullish Q4 CY2025
Insurance and technology company HCI Group (NYSE:HCI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 52.1% year on year to $246.2 million. Its GAAP profit of $7.25 per share was 58.5% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Zevia (NYSE:ZVIA) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops
Beverage company Zevia (NYSE:ZVIA) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 4% year on year to $37.87 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $41 million at the midpoint, or 1.2% above analysts’ estimates. Its GAAP loss of $0.02 per share was in line with analysts’ consensus estimates.
Via StockStory · February 25, 2026
Red Robin’s (NASDAQ:RRGB) Q4 CY2025 Sales Beat Estimates, Stock Jumps 28.4%
Burger restaurant chain Red Robin (NASDAQ:RRGB) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 5.7% year on year to $269 million. Its non-GAAP loss of $0.41 per share was 30.2% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
The Honest Company (NASDAQ:HNST) Reports Q4 CY2025 In Line With Expectations But Stock Drops
Personal care company The Honest Company (NASDAQ:HNST) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 11.8% year on year to $88.04 million. Its GAAP loss of $0.21 per share was significantly below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Northwest Pipe’s (NASDAQ:NWPX) Q4 CY2025 Sales Top Estimates
Water management company Northwest Pipe (NASDAQ:NWPX) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 5% year on year to $125.6 million. Its non-GAAP profit of $0.93 per share was 50% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Chemed (NYSE:CHE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops 14.7%
Healthcare services company Chemed Corporation (NYSE:CHE) fell short of the market’s revenue expectations in Q4 CY2025, with sales flat year on year at $639.3 million. Its non-GAAP profit of $6.42 per share was 8.7% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Encore Capital Group (NASDAQ:ECPG) Delivers Strong Q4 CY2025 Numbers
Debt recovery company Encore Capital Group (NASDAQ:ECPG) announced better-than-expected revenue in Q4 CY2025, with sales up 78.3% year on year to $473.6 million. Its GAAP profit of $3.37 per share was 51.1% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
CBIZ (NYSE:CBZ) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Financial services provider CBIZ (NYSE:CBZ) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 17.9% year on year to $542.7 million. The company’s full-year revenue guidance of $2.85 billion at the midpoint came in 1.8% below analysts’ estimates. Its non-GAAP loss of $0.70 per share was 6.2% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
BJ’s (NASDAQ:BJRI) Q4 CY2025: Beats On Revenue
American restaurant chain BJ’s Restaurants (NASDAQ:BJRI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 3.2% year on year to $355.4 million. Its non-GAAP profit of $0.66 per share was 5.7% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars
Medical device company LeMaitre Vascular (NASDAQ:LMAT) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15.7% year on year to $64.45 million. Guidance for next quarter’s revenue was better than expected at $66.6 million at the midpoint, 0.7% above analysts’ estimates. Its GAAP profit of $0.68 per share was 2.5% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Marriott Vacations’s (NYSE:VAC) Q4 CY2025: Beats On Revenue, Stock Soars
Vacation ownership company Marriott Vacations (NYSE:VAC) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $1.32 billion. Its non-GAAP profit of $1.86 per share was 9% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Array’s (NASDAQ:ARRY) Q4 CY2025 Sales Beat Estimates But Stock Drops 23.2%
Solar tracking systems manufacturer Array (NASDAQ:ARRY) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 17.9% year on year to $226 million. The company expects the full year’s revenue to be around $1.45 billion, close to analysts’ estimates. Its non-GAAP profit of $0.01 per share was in line with analysts’ consensus estimates.
Via StockStory · February 25, 2026
Energy Recovery (NASDAQ:ERII) Misses Q4 CY2025 Revenue Estimates, Stock Drops 18.7%
Energy recovery device manufacturer Energy Recovery (NASDAQ:ERII) missed Wall Street’s revenue expectations in Q4 CY2025, with sales flat year on year at $66.87 million. Its non-GAAP profit of $0.53 per share was 20.9% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Teladoc (NYSE:TDOC) Surprises With Q4 CY2025 Sales
Digital medical services platform Teladoc Health (NYSE:TDOC) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $642.3 million. On the other hand, next quarter’s revenue guidance of $609 million was less impressive, coming in 3.8% below analysts’ estimates. Its GAAP loss of $0.14 per share was 24% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Barrett (NASDAQ:BBSI) Misses Q4 CY2025 Sales Expectations
Business management solutions provider Barrett Business Services (NASDAQ:BBSI) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.3% year on year to $321.1 million. Its GAAP profit of $0.64 per share was in line with analysts’ consensus estimates.
Via StockStory · February 25, 2026
The Pennant Group’s (NASDAQ:PNTG) Q4 CY2025 Sales Top Estimates
Senior living provider The Pennant Group (NASDAQ:PNTG) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 53.3% year on year to $289.3 million. The company expects the full year’s revenue to be around $1.15 billion, close to analysts’ estimates. Its non-GAAP profit of $0.34 per share was 7.7% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
TaskUs (NASDAQ:TASK) Beats Q4 CY2025 Sales Expectations, Stock Soars
Digital outsourcing company TaskUs (NASDAQ:TASK) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 14.1% year on year to $313 million. The company expects next quarter’s revenue to be around $297 million, close to analysts’ estimates. Its non-GAAP profit of $0.40 per share was 11% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
C3.ai (NYSE:AI) Misses Q4 CY2025 Revenue Estimates, Stock Drops 20.6%
Enterprise AI software company C3.ai (NYSE:AI) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 46.1% year on year to $53.26 million. Next quarter’s revenue guidance of $50 million underwhelmed, coming in 35.9% below analysts’ estimates. Its GAAP loss of $0.94 per share was 24% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
IonQ (NYSE:IONQ) Reports Bullish Q4 CY2025, Stock Soars
Quantum computing company IonQ (NYSE:IONQ) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 429% year on year to $61.89 million. The company’s full-year revenue guidance of $235 million at the midpoint came in 22% above analysts’ estimates. Its non-GAAP loss of $0.20 per share was 13% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Zoom (NASDAQ:ZM) Exceeds Q4 CY2025 Expectations, Guides For 4.1% Growth Next Year
Video communications platform Zoom (NASDAQ:ZM) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5.3% year on year to $1.25 billion. The company expects next quarter’s revenue to be around $1.22 billion, close to analysts’ estimates. Its non-GAAP profit of $1.44 per share was 3.1% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Magnite (NASDAQ:MGNI) Misses Q4 CY2025 Revenue Estimates
Digital advertising platform Magnite (NASDAQ:MGNI) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.9% year on year to $205.4 million. Its non-GAAP profit of $0.34 per share was 3.9% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Fidelis Insurance (NYSE:FIHL) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Specialty insurance provider Fidelis Insurance (NYSE:FIHL) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 10.8% year on year to $600.9 million. Its non-GAAP profit of $1.09 per share was 1.3% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Redwire (NYSE:RDW) Beats Q4 CY2025 Sales Expectations But Stock Drops
Aerospace and defense company Redwire (NYSE:RDW) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 56.4% year on year to $108.8 million. The company’s full-year revenue guidance of $475 million at the midpoint came in 2.1% above analysts’ estimates. Its GAAP loss of $0.58 per share was significantly below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Nvidia’s (NASDAQ:NVDA) Q4 Sales Top Estimates, Inventory Levels Improve
Leading designer of graphics chips Nvidia (NASDAQ:NVDA) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 73.2% year on year to $68.13 billion. On top of that, next quarter’s revenue guidance ($78 billion at the midpoint) was surprisingly good and 8.1% above what analysts were expecting. Its non-GAAP profit of $1.62 per share was 5.3% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
agilon health’s (NYSE:AGL) Q4 CY2025 Sales Top Estimates
Healthcare services company Agilon Health (NYSE:AGL) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 3.1% year on year to $1.57 billion. On the other hand, next quarter’s revenue guidance of $1.37 billion was less impressive, coming in 12.6% below analysts’ estimates. Its GAAP loss of $0.46 per share was 69.1% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
IMAX (NYSE:IMAX) Delivers Strong Q4 CY2025 Numbers, Stock Soars
Premium cinema technology company IMAX (NYSE:IMAX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 35.1% year on year to $125.2 million. Its non-GAAP profit of $0.58 per share was 22.9% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Universal Health Services (NYSE:UHS) Misses Q4 CY2025 Sales Expectations
Hospital management company Universal Health Services (NYSE:UHS) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 9.1% year on year to $4.49 billion. On the other hand, the company’s full-year revenue guidance of $18.6 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $5.88 per share was 0.5% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Root (NASDAQ:ROOT) Delivers Strong Q4 CY2025 Numbers, Stock Jumps 12.2%
Digital auto insurance company Root (NASDAQ:ROOT) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 21.5% year on year to $397 million. Its GAAP profit of $0.31 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 25, 2026
FTAI Aviation (NASDAQ:FTAI) Misses Q4 CY2025 Sales Expectations
Aircraft leasing company FTAI Aviation (NASDAQ:FTAI) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 32.7% year on year to $662 million. Its GAAP profit of $1.08 per share was 13.2% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Snowflake’s (NYSE:SNOW) Q4 CY2025 Sales Beat Estimates
Cloud data platform provider Snowflake (NYSE:SNOW) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 30.1% year on year to $1.28 billion. Its non-GAAP profit of $0.32 per share was 17.8% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
NerdWallet (NASDAQ:NRDS) Reports Strong Q4 CY2025 But Stock Drops
Financial guidance platform NerdWallet (NASDAQ:NRDS) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 22.6% year on year to $225.4 million. Its GAAP profit of $0.19 per share was 8.9% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Agilent (NYSE:A) Reports Q4 CY2025 In Line With Expectations
Life sciences tools company Agilent Technologies (NYSE:A) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 7% year on year to $1.8 billion. The company expects next quarter’s revenue to be around $1.81 billion, coming in 2.2% above analysts’ estimates. Its non-GAAP profit of $1.36 per share was in line with analysts’ consensus estimates.
Via StockStory · February 25, 2026
MYR Group (NASDAQ:MYRG) Delivers Strong Q4 CY2025 Numbers
Electrical construction and infrastructure services provider MYR Group (NASDAQ:MYRG) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 17.3% year on year to $973.5 million. Its GAAP profit of $2.33 per share was 30.5% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
The Trade Desk (NASDAQ:TTD) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops 15.6%
Digital advertising platform The Trade Desk (NASDAQ:TTD) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 14.3% year on year to $846.8 million. On the other hand, next quarter’s revenue guidance of $678 million was less impressive, coming in 1.5% below analysts’ estimates. Its non-GAAP profit of $0.59 per share was in line with analysts’ consensus estimates.
Via StockStory · February 25, 2026
Salesforce’s (NYSE:CRM) Q4 CY2025 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next Year
CRM software giant Salesforce (NYSE:CRM) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 12.1% year on year to $11.2 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $46 billion at the midpoint. Its non-GAAP profit of $3.81 per share was 24.9% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Churchill Downs’s (NASDAQ:CHDN) Q4 CY2025 Sales Top Estimates
Racing, gaming, and entertainment company Churchill Downs (NASDAQ:CHDN) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.7% year on year to $665.9 million. Its non-GAAP profit of $0.97 per share was 5.4% below analysts’ consensus estimates.
Via StockStory · February 25, 2026
Pure Storage’s (NYSE:PSTG) Q4 CY2025 Sales Top Estimates
Data storage solutions provider Pure Storage (NYSE:PSTG) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 20.4% year on year to $1.06 billion. On top of that, next quarter’s revenue guidance ($1 billion at the midpoint) was surprisingly good and 8.1% above what analysts were expecting. Its non-GAAP profit of $0.69 per share was 7% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Sinclair (NASDAQ:SBGI) Reports Q4 CY2025 In Line With Expectations
Media broadcasting company Sinclair (NASDAQ:SBGI) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 16.7% year on year to $836 million. On the other hand, the company’s full-year revenue guidance of $3.47 billion at the midpoint came in 0.8% below analysts’ estimates. Its GAAP profit of $1.55 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Penumbra (NYSE:PEN) Reports Bullish Q4 CY2025
Medical device company Penumbra (NYSE:PEN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 22.1% year on year to $385.4 million. Its non-GAAP profit of $1.18 per share was 6.1% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Robinhood (HOOD) Stock Trades Up, Here Is Why
Shares of financial services company Robinhood (NASDAQ:HOOD) jumped 5.9% in the afternoon session after a rally in Bitcoin renewed expectations for increased trading activity on its platform. 
Via StockStory · February 25, 2026
Strategy (MSTR) Stock Trades Up, Here Is Why
Shares of bitcoin development company Strategy (NASDAQ:MSTR) jumped 9% in the afternoon session after a rally in the price of Bitcoin created upward pressure on the heavily shorted stock. 
Via StockStory · February 25, 2026
Why Is MarineMax (HZO) Stock Soaring Today
Shares of boat and marine products retailer MarineMax (NYSE:HZO) jumped 8.8% in the afternoon session after reports surfaced that more potential buyers, including private equity firms Blackstone and Centerbridge Partners, expressed interest in acquiring the company. 
Via StockStory · February 25, 2026
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
Shares of biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) jumped 13.5% in the afternoon session after the company reported better-than-expected fourth-quarter 2025 revenue and earnings. 
Via StockStory · February 25, 2026
Why Flywire (FLYW) Stock Is Up Today
Shares of global payments company Flywire (NASDAQ:FLYW) jumped 10.1% in the afternoon session after it reported fourth-quarter 2025 results that beat Wall Street's expectations for both revenue and earnings. Revenue grew 39.7% year-over-year to $157.5 million, surpassing analyst estimates by 9.3%. The company also posted a GAAP earnings per share of $0.00, which was an upside surprise to analysts who had forecast a loss of $0.01 per share. In addition, adjusted EBITDA of $25.4 million came in nearly 10% ahead of consensus. Overall, the significant top- and bottom-line beats drove the positive investor sentiment.
Via StockStory · February 25, 2026
Target Hospitality (TH) Shares Skyrocket, What You Need To Know
Shares of workforce housing company Target Hospitality (NASDAQ:TH) jumped 6.5% in the afternoon session after it announced a second 400-bed expansion to a workforce community supporting data center development, significantly increasing its capacity and future revenue. 
Via StockStory · February 25, 2026
Why Super Micro (SMCI) Stock Is Trading Up Today
Shares of server solutions provider Super Micro (NASDAQ:SMCI) jumped 8% in the afternoon session after the company made two significant announcements: a successful test of its AI infrastructure as a high-speed 'Virtual Power Plant' and the launch of a new enterprise AI data platform. 
Via StockStory · February 25, 2026
Why Are Pure Storage (PSTG) Shares Soaring Today
Shares of data storage solutions provider Pure Storage (NYSE:PSTG) jumped 9.6% in the afternoon session after the company announced a major rebranding to 'Everpure' and its intent to acquire data intelligence firm 1touch, signaling a strategic shift ahead of its earnings report. 
Via StockStory · February 25, 2026
Evolent Health (EVH) Shares Skyrocket, What You Need To Know
Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 20.7% in the afternoon session after the company reported fourth-quarter earnings that beat expectations and provided an optimistic revenue forecast for the upcoming year. 
Via StockStory · February 25, 2026
Why Resideo (REZI) Stock Is Trading Up Today
Shares of home automation and security solutions provider Resideo Technologies (NYSE:REZI) jumped 13.5% in the afternoon session after the company reported fourth-quarter revenue that topped Wall Street estimates and provided an upbeat financial outlook for 2026. Resideo's sales in the fourth quarter rose 2% year-on-year to $1.90 billion, edging past analysts' expectations. However, the company's adjusted earnings of $0.50 per share fell short of consensus estimates by 4.5%. Investors appeared to focus on the company's strong forecast. For the upcoming first quarter, Resideo guided for revenue of $1.88 billion at the midpoint, which was 4.6% higher than what analysts had anticipated. Furthermore, its full-year 2026 guidance was a highlight, with projections for adjusted earnings per share and EBITDA beating consensus estimates by 11% and 5% respectively. The optimistic outlook suggests management expects robust performance ahead, outweighing the mixed results of the past quarter.
Via StockStory · February 25, 2026
Why Federal Signal (FSS) Stock Is Up Today
Shares of safety and security company Federal Signal (NYSE:FSS) jumped 6% in the morning session after the company reported strong fourth-quarter 2025 results that surpassed Wall Street's expectations and provided an upbeat financial outlook for 2026. 
Via StockStory · February 25, 2026
Why MercadoLibre (MELI) Shares Are Getting Obliterated Today
Shares of latin American e-commerce and fintech company MercadoLibre (NASDAQ:MELI) fell 10% in the morning session after the company reported mixed fourth quarter results. 
Via StockStory · February 25, 2026
Why Steven Madden (SHOO) Stock Is Trading Lower Today
Shares of shoe and apparel company Steven Madden (NASDAQ:SHOO) fell 5.4% in the morning session after it reported fourth-quarter results that showed a significant decline in profitability, overshadowing a strong beat on adjusted EBITDA. 
Via StockStory · February 25, 2026
Why Is Axon (AXON) Stock Rocketing Higher Today
Shares of self defense company AXON (NASDAQ:AXON) jumped 23.8% in the morning session after it reported strong fourth-quarter financial results that beat Wall Street's expectations and provided an upbeat outlook for the future. 
Via StockStory · February 25, 2026
Articles from StockStory | MarketMinute